The Motley Fool UK

Fool UK: Investment Advice | Share Research

Most Recent

How Did AstraZeneca plc End Up Thrashing Rival GlaxoSmithKline plc?

AstraZeneca plc (LON: AZN) has handed out a real thrashing to pharmaceutical rival GlaxoSmithKline plc (LON: GSK) lately, but Harvey Jones suggests the tables... read more »

26% Growth At Standard Chartered PLC!

Standard Chartered PLC (LON: STAN) looks set to take off. read more »

Play The Percentages With Barclays PLC

How reliable are earnings forecasts for Barclays PLC (LON:BARC) -- and is the stock attractively priced right now? read more »

Beginners Portfolio: Apple Inc Confounds The Critics

We have good news from Apple Inc (NASDAQ: AAPL) and GlaxoSmithKline (LON: GSK). read more »

What Dividend Hunters Need To Know About Lloyds Banking Group PLC

Royston Wild looks at whether Lloyds Banking Group PLC (LON: LLOY) is an attractive income stock. read more »

Will Patisserie Valerie Deliver Sweet Returns?

VIDEO: A Fool looks into the "home of fine cakes and gateaux. read more »

(Video) GlaxoSmithKline plc Gives Up On Cancer

One Fool puts GlaxoSmithKline plc (LON:GSK) under the spotlight. read more »

Where Would You Put Your Money: Unilever plc Or Reckitt Benckiser Group plc?

VIDEO: Two Fools puts Unilever plc (LON:ULVR) and Reckitt Benckiser Group plc (LON:RB) under the spotlight. read more »

There’s A 14% Slump Ahead For AstraZenenca plc

Recovery might be coming for AstraZeneca plc (LON: AZN), but it'll take a few more years. read more »

Play The Percentages With Diageo plc

How reliable are earnings forecasts for Diageo plc (LON:DGE) -- and is the stock attractively priced right now? read more »